U.S. Banks Stock News

NasdaqGS:FRME
NasdaqGS:FRMEBanks

Is It Time To Reassess First Merchants (FRME) After Recent Share Price Stability?

If you are looking at First Merchants and wondering whether the current share price still represents good value, you are not alone. The stock last closed at US$42.05, with returns of 0.5% over the past 7 days, 11.7% over 30 days, 12.1% year to date and a 1% decline over the past year, which may signal changing expectations around its prospects and risk. This article was prompted by Simply Wall St's evergreen coverage of First Merchants, which periodically refreshes to keep valuation and...
NasdaqGS:TW
NasdaqGS:TWCapital Markets

Is It Too Late To Consider Tradeweb Markets (TW) After Recent Electronic Trading Headlines?

If you are wondering whether Tradeweb Markets is pricing in too much optimism or not enough, the next sections will walk through what the current share price might be implying about the business. The stock recently closed at US$115.02, with returns of 14.1% over the last 7 days, 9.6% over the last 30 days, 8.3% year to date, 53.8% over 3 years and 73.0% over 5 years. The 1 year return sits at a 9.0% decline. Recent news coverage around Tradeweb Markets has focused on its role as an...
NYSE:ALLE
NYSE:ALLEBuilding

Does Allegion’s 12th Dividend Hike Reveal a Deeper Capital Allocation Shift for ALLE?

Allegion plc recently declared a quarterly dividend of US$0.55 per ordinary share, an 8% increase from 2025 and its 12th consecutive annual dividend raise, payable on March 31, 2026 to shareholders of record on March 13, 2026. This extended streak of rising dividends highlights Allegion’s ongoing focus on returning cash to shareholders while signaling confidence in its ability to sustain such payouts. With Allegion’s 8% dividend increase underscoring its emphasis on shareholder returns,...
NYSE:MNTN
NYSE:MNTNMedia

MNTN (MNTN) Turns First Quarterly Profit And Tests Bullish Narratives

MNTN (MNTN) has put a cleaner set of numbers on the table for FY 2025 so far, with Q3 revenue of US$70.0 million and basic EPS of US$0.09 off net income of US$6.4 million, against a trailing twelve month backdrop that still shows a loss of US$44.9 million on revenue of US$272.8 million and EPS of US$1.25. The company has seen quarterly revenue move from US$54.8 million in Q2 2024 to US$70.0 million in Q3 2025. EPS has swung across losses of US$0.69, US$1.41 and US$0.65 in early FY 2025 before...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW) Margin Compression To 17.5% Tests Premium P/E Narrative

Edwards Lifesciences FY 2025 earnings snapshot Edwards Lifesciences (EW) has wrapped up FY 2025 with fourth quarter revenue of US$1,569.6 million and basic EPS of US$0.11, setting the tone for how investors assess the latest stretch of results. The company has seen revenue move from US$1,385.8 million in Q4 2024 to US$1,569.6 million in Q4 2025, while basic EPS over that same period went from US$0.59 to US$0.11. This puts the focus squarely on how efficiently those sales are translating into...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics MRD Blood Test May Support Growth In Higher Value Oncology

Quest Diagnostics (NYSE:DGX) has introduced a blood based minimal residual disease test for multiple myeloma that uses advanced flow cytometry. The company reports that the assay offers sensitivity comparable to next generation sequencing with a lower expected cost and less invasive sampling. FDA draft guidance recognizes minimal residual disease as an endpoint in multiple myeloma clinical trials, supporting broader use of MRD testing in research. For you as an investor, this development...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

A Look At Construction Partners (ROAD) Valuation After Strong Q1 Results And Upgraded Outlook

Construction Partners (ROAD) has just combined a strong quarterly update with a raised full year outlook, after reporting higher first quarter sales and a move from loss to profit compared with a year earlier. See our latest analysis for Construction Partners. The strong quarterly beat and upgraded guidance have coincided with a sharp pick up in momentum, with a 1 month share price return of 14.62% and a 1 year total shareholder return of 66.51% building on a very large 5 year total...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab’s First Profitable Year Resets Capital Returns And Growth Plans

Grab Holdings (NasdaqGS:GRAB) reports its first full year of net profit. The company launches a $500 million share buyback program. Grab announces the acquisition of Stash Financial to expand into wealth services. Grab partners with Hesai Technology to distribute lidar products across Southeast Asia. Grab Holdings is moving through a major shift, pairing its first full year of net profit with several new capital and business moves. The share price sits at $4.23, with a 3 year return of...
NYSEAM:UEC
NYSEAM:UECOil and Gas

Is Uranium Energy (UEC) Pricing In Too Much Optimism After Strong Multi Year Rally

If you are wondering whether Uranium Energy's current share price reflects its true worth, you are not alone. The stock has attracted plenty of attention from investors trying to work out what is already priced in. Over the short term, the share price performance has been mixed, with a 1.2% decline over the last 7 days and a 0.3% decline over the last 30 days. Year to date it is up 21.3%, the 1 year return stands at 125.2%, and the 3 year return is very large. Recent headlines around Uranium...
NYSE:BLSH
NYSE:BLSHCapital Markets

Assessing Bullish (BLSH) Valuation After ARK Invest Buying And U.S. Expansion News

Interest around Bullish (BLSH) has picked up after ARK Invest disclosed sizable purchases of the stock, following quarterly results that combined reported revenue growth with a large net loss for 2025. See our latest analysis for Bullish. The recent ARK purchases and Bullish’s U.S. expansion news arrived after a 17.21% 7 day share price return. However, that move sits against a 30 day share price return of 20.30% and a year to date share price return of an 18.80% decline, hinting that...
NYSE:AKR
NYSE:AKRRetail REITs

Acadia Leadership Transition Raises Questions On Reporting Strength And Growth

Acadia Realty Trust (NYSE:AKR) announced internal executive promotions tied to the planned retirement of its long-tenured Chief Administrative Officer, Joseph Napolitano. Erica Pipitone has been promoted to Vice President of Financial Reporting as part of the updated leadership structure. Napolitano is set to retire after 31 years with the company, marking a significant shift in its senior administrative team. Acadia Realty Trust focuses on retail real estate, so leadership in finance and...
NYSE:HNI
NYSE:HNICommercial Services

HNI Dividend Track Record Meets Undervalued Share Price And Low Debt

HNI Corporation (NYSE:HNI) has maintained consistent dividend payments for more than 10 years. The company highlights low debt levels and improving profit margins as support for its dividend record. This update is relevant for investors who prioritize stable income and financial resilience. HNI Corporation, listed on the NYSE under the ticker HNI, focuses on office furniture and hearth products, areas that tie closely to commercial real estate, home improvement, and workplace trends. For...
NYSE:ICE
NYSE:ICECapital Markets

Is Intercontinental Exchange (ICE) Pricing Look Stretched After Recent Share Price Weakness

If you are wondering whether Intercontinental Exchange at around US$151.99 is offering fair value or a potential mispricing, you are not alone. That is exactly what this article aims to unpack. The stock has seen mixed returns, with a 7.8% decline over the last 7 days, an 8.6% decline over 30 days and a 5.0% decline year to date, set against longer term gains of 45.5% over 3 years and 43.7% over 5 years. Recent coverage around Intercontinental Exchange has focused on its role in global...
NasdaqCM:IMTX
NasdaqCM:IMTXBiotechs

Assessing Immatics (NasdaqCM:IMTX) Valuation After FDA Orphan Drug Designation For Its Melanoma Program

FDA orphan drug designation puts Immatics (NasdaqCM:IMTX) melanoma program in focus Immatics (NasdaqCM:IMTX) is back on investor radars after the FDA granted orphan drug designation to its melanoma treatment for HLA-A 02:01-positive patients with Stage II and higher disease. See our latest analysis for Immatics. The orphan drug news lands after a sharp shift in sentiment, with the 1-year total shareholder return of 102.17% and recent 7-day and 30-day share price returns of 9.74% and 11.90%...
NYSE:QGEN
NYSE:QGENLife Sciences

Qiagen’s Greener Lab Automation Push And What It Could Mean For Growth

Qiagen (NYSE:QGEN) has introduced sustainability-focused consumables and new automated sample preparation systems for clinical laboratories. The lineup features the newly launched QIAsprint Connect, with QIAsymphony Connect and QIAmini planned to broaden automation options across different lab sizes. The company is positioning these platforms to support greener lab workflows and greater process efficiency in clinical testing environments. Qiagen is putting more attention on automation and...
NasdaqGM:BWMN
NasdaqGM:BWMNConstruction

3 Growth Companies To Watch With Insider Ownership Up To 19%

As February begins, the U.S. stock market has shown a strong start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting investor optimism amid recent economic developments such as trade agreements and manufacturing growth. In this buoyant market environment, identifying growth companies with substantial insider ownership can be particularly compelling for investors seeking alignment between company leadership and shareholder interests.
NasdaqCM:RPID
NasdaqCM:RPIDLife Sciences

February 2026's Standout Penny Stocks To Consider

As February begins, the U.S. stock market is off to a strong start, with major indexes like the Dow Jones and S&P 500 posting significant gains. In such a buoyant market environment, investors often look beyond traditional stocks for opportunities that might offer substantial returns at lower entry points. Penny stocks, while an outdated term, still represent an intriguing investment area where smaller or newer companies can provide growth potential when underpinned by solid financials and...
NasdaqGS:XNET
NasdaqGS:XNETSoftware

US Market's Undiscovered Gems To Watch In February 2026

As February 2026 begins, the U.S. stock market is experiencing a strong upswing, with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. This positive momentum comes amid broader economic developments such as trade deals and manufacturing growth, creating an environment ripe for identifying promising small-cap stocks that may have been overlooked. In this vibrant market landscape, a good stock often combines solid fundamentals with growth potential that...
NYSE:TJX
NYSE:TJXSpecialty Retail

Is It Too Late To Consider TJX Companies (TJX) After Strong Multi Year Share Gains

If you are wondering whether TJX Companies is still good value at around US$150.75 per share, you are not alone. Many investors are asking if the current price fairly reflects the off price retailer's strengths and risks. The stock has seen a 2.1% decline over the past week and a 4.0% decline over the last month, yet it sits on a 23.0% return over 1 year, 94.7% over 3 years and 142.7% over 5 years, which raises questions about what is already priced in. Recent coverage around TJX has focused...